📈 Jumpstart Signal Watchlist — August 14, 2026

🏢 What they do: Mitek Systems, Inc. (MITK) specializes in digital identity verification, authentication, biometrics, mobile image capture, and fraud detection solutions. Its enterprise-grade platform enables secure onboarding, check deposits, transaction protection, and real-time defense against threats like deepfakes and synthetic fraud for banks, fintechs, and other organizations.
- 🎯 Current $19.43 is 4% below 3yr high $20.14 · ⏳ SMA200 $13.58 (current price $19.43 is above) · 💰 Market Cap $876M
- MITK shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 240% (>20%); Revenue growth 18% (>15%); Low LT D/E 0.20 (<1.0); PEG ratio 0.17 (<1.5).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (7.6%)
- 🔔 Strong above EMA50 (10.6%)
- 📈 RSI at 63 showing strength
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ Mitek Reports Fiscal Third Quarter Revenue of $54.0 Million, Up 18% Year-Over-Year; Raises Full-Year Outlook — Business Wire.
🤖 Mitek reported Q3 fiscal 2026 revenue of $54.0 million, beat expectations, and raised its full-year revenue and adjusted EBITDA margin outlook. The update also included a new CRO appointment and board leadership changes, which reinforce operational momentum.
✅ Mitek Systems (MITK) Q3 Earnings and Revenues Beat Estimates — Yahoo Finance.
🤖 The company beat consensus on both EPS and revenue for the quarter ended June 2026. Beating estimates and showing year-over-year revenue growth are favorable for the stock.
⚪️ Mitek Systems (NASDAQ:MITK) Stock Crosses Above 200-Day Moving Average - Here's What Happened — MarketBeat.
🤖 This is mainly a technical trading update showing the stock moved above its 200-day moving average. It mentions the recent earnings beat, but the article itself is more about price action than new fundamental information.
🍭 Bonus (B): 10/10 — Computer Peripheral Equipment (Technology sector)

🏢 What they do: MeiraGTx Holdings plc is a clinical-stage genetic medicines company that develops gene therapies and other genetic medicine platforms for both rare and more common diseases. Its work includes programs in eye diseases, Parkinson’s disease, and radiation-induced dry mouth, along with its riboswitch technology for controlled delivery of biologic therapies.
- 🎯 Current $13.52 is 8% below 3yr high $14.66 · ⏳ SMA200 $9.28 (current price $13.52 is above) · 💰 Market Cap $1.3B
- MGTX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 38/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; SMA50 recent crossover; SMA50 recent crossover; EPS growth 456% (>20%); PEG ratio 0.04 (<1.5).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA21 (7.4%)
- 🔔 Strong above EMA50 (13.2%)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ MeiraGTx (NASDAQ:MGTX) Trading 8.4% Higher Following Strong Earnings — MarketBeat.
🤖 The company reported Q2 EPS of $1.71, far above expectations for a loss, and disclosed major pipeline progress including FDA Breakthrough Therapy Designation and positive long-term Phase 1 data. It also highlighted improved financing and development opportunities, which is supportive for the stock.
✅ MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Objective at Royal Bank of Canada — MarketBeat.
🤖 Royal Bank of Canada raised its price target on MGTX from $26 to $27, signaling continued analyst confidence in the company’s outlook. A higher target can support sentiment by implying more upside from current trading levels.
❌ MeiraGTx CFO & COO Giroux sells $700,560 in shares — Investing.com.
🤖 An insider sale can weigh on sentiment because it may suggest management is taking some profits after a stock run. The article also notes the shares had already rallied substantially, which can make the sale look less favorable to investors.
⚪️ Rubric Capital Management LP Acquires 824669 Shares of MeiraGTx Holdings PLC $MGTX — MarketBeat.
🤖 The article reports a larger institutional position in MGTX, which can be read as a vote of confidence, but it also mixes in insider selling and prior financial results without a single clear catalyst. On balance, the ownership change is supportive but not strongly price-moving by itself.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Quad/Graphics is a marketing experience company that provides print and related marketing services. Its offerings include printing for magazines, catalogs, direct mail, packaging, and retail inserts, along with creative, media, data, and digital marketing services.
- 🎯 Current $9.94 is 8% below 3yr high $10.85 · ⏳ SMA200 $7.06 (current price $9.94 is above) · 💰 Market Cap $474M
- QUAD shows decent technicals supported by positive sentiment.

💎 Quality (Q): 40/60
- 🏦 Low drawdown (14.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; PEG ratio 0.98 (<1.5).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA50 (12.5%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Quad Reports Second Quarter and Year-to-Date 2026 Results — PR Newswire.
🤖 Quad reported Q2 2026 EPS of $0.24 and revenue of $578 million, both strong enough to support a positive read-through for the stock. It also reaffirmed full-year 2026 guidance and described share repurchases and a dividend, which are constructive for shareholder returns.
✅ Quad Graphics (NYSE:QUAD) Hits New 52-Week High on Better-Than-Expected Earnings — MarketBeat.
🤖 This article frames the Q2 beat as a catalyst for QUAD reaching a new 52-week high. It is bullish because it highlights earnings and revenue coming in above estimates and notes continued favorable analyst positioning.
✅ Quad Graphics Q2 Earnings Call Highlights — MarketBeat.
🤖 The piece emphasizes that Quad’s Q2 results met expectations and that management reaffirmed 2026 guidance. Reaffirmed guidance and improving free cash flow are supportive signals for the stock.
🍭 Bonus (B): 0/10 — Printing & Publishing

🏢 What they do: Bioventus Inc. is a global medical device company that develops and commercializes clinically proven, minimally invasive products to relieve pain and address musculoskeletal challenges by enhancing the body's natural healing process .
- 🎯 Current $14.26 is 7% below 3yr high $15.26 · ⏳ SMA200 $9.14 (current price $14.26 is above) · 💰 Market Cap $964M
- BVS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 327% (>20%); ROE 24% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.06 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.9%)
- 🔔 Strong above EMA50 (19.2%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Bioventus Reports Second Quarter Financial Results — GlobeNewswire.
🤖 Bioventus reported 4% revenue growth, higher GAAP EPS, and reaffirmed full-year 2026 guidance. The company also announced a strategic alternatives review after receiving an unsolicited acquisition proposal, which can support the stock if it leads to a sale or other value-creating outcome.
✅ Bioventus Inc (BVS) (Q2 2026) Earnings Call Highlights — GuruFocus News.
🤖 The article highlights solid Q2 performance, including revenue growth, expanding EBITDA margins, and strong cash flow. It also notes reduced leverage and reaffirmed guidance, all of which are favorable for BVS.
✅ Bioventus Q2 2026 slides: profits rise, strategic review underway — Investing.com.
🤖 This piece says Bioventus posted stronger profits, beat adjusted EPS expectations, and reaffirmed full-year guidance. The strategic review adds potential upside if it results in a transaction or better valuation.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $58.71 is 2% below 3yr high $59.82 · ⏳ SMA200 $30.78 (current price $58.71 is above) · 💰 Market Cap $77.7B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 154% (>20%); Revenue growth 40% (>15%); Low LT D/E 0.86 (<1.0); PEG ratio 0.35 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (12.8%)
- 🔔 Strong above EMA50 (23.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ HPE shares jump 5% as Morgan Stanley upgrade points to nearly 30% upside — Yahoo Finance.
🤖 Morgan Stanley upgraded HPE to Overweight and set a $69 target, citing an increasingly attractive outlook for earnings, cash generation, and valuation. The upgrade helped push the shares higher, which is constructive for near-term sentiment.
✅ HPE will gain ground on sky-high hardware demand, Morgan Stanley says — CNBC.
🤖 Morgan Stanley said HPE should benefit from strong enterprise hardware demand and AI-related spending, reinforcing a bullish view on the stock. The higher price target and upgrade suggest improving analyst confidence in HPE’s growth outlook.
⚪️ Hewlett Packard Enterprise Company (NYSE:HPE) Given Consensus Rating of Moderate Buy by Brokerages — MarketBeat.
🤖 Brokerages maintained an overall Moderate Buy stance with an average target above the market price, which is supportive but not a fresh catalyst. This is neutral because it confirms existing sentiment rather than changing the outlook materially.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Remitly Global, Inc. is a digital financial services provider that offers cross-border remittance and international money transfer services primarily for immigrants and their families through a mobile app and website .
- 🎯 Current $26.30 is 5% below 3yr high $27.59 · ⏳ SMA200 $17.81 (current price $26.30 is above) · 💰 Market Cap $5.6B
- RELY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 3000% (>20%); Revenue growth 20% (>15%); ROE 27% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 4/20
- 🔔 Strong above EMA21 (9.2%)
- 🔔 Strong above EMA50 (14.3%)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Remitly Global launches the Global Card for cross-border communities — GlobeNewswire.
🤖 Remitly introduced a new Global Card product that expands the company beyond remittances into broader everyday financial services. The phased rollout and multi-market expansion could support longer-term growth and engagement for RELY.
✅ Remitly reports record second-quarter results and raises full-year 2026 outlook — GlobeNewswire.
🤖 Remitly posted strong Q2 2026 results, including higher revenue, send volume, active customers, and adjusted EBITDA, and also raised its full-year outlook. That combination is typically supportive for the stock because it signals improving fundamentals and management confidence.
✅ Cantor raises Remitly stock price target to $30 on guidance boost — Investing.com.
🤖 Cantor Fitzgerald increased its price target on RELY while keeping an Overweight rating, citing the company’s improved outlook. A higher target from a major analyst can boost sentiment by reinforcing the post-earnings growth story.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Flotek Industries, Inc. is a chemistry and data analytics company serving the energy industry, especially oil and gas. It develops and markets specialty chemicals, logistics, and technology services along with real-time data analytics equipment and services to help customers improve efficiency, reduce costs, and lower environmental impact.
- 🎯 Current $35.83 is 8% below 3yr high $38.82 · ⏳ SMA200 $19.15 (current price $35.83 is above) · 💰 Market Cap $1.3B
- FTK shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 420% (>20%); Revenue growth 70% (>15%); ROE 29% (>15%); Low LT D/E 0.31 (<1.0).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA21 (15.4%)
- 🔔 Strong above EMA50 (33.0%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Flotek Q2 2026 slides: $400M Puerto Rico deal caps record quarter — Investing.com.
🤖 Flotek reported a record second quarter, announced a 10-year $400 million Puerto Rico contract, and raised full-year guidance. The combination of stronger backlog, higher revenue, and improved outlook is favorable for $FTK.
✅ Flotek Industries Inc (FTK) (Q2 2026) Earnings Call Highlights — Yahoo Finance.
🤖 The company said revenue rose 70% year over year and adjusted EBITDA increased 109%, while net income reached $10 million. Management also raised 2026 guidance, which supports a bullish view of $FTK.
✅ Flotek Industries (FTK) Q2 Earnings and Revenues Top Estimates — Yahoo Finance.
🤖 Flotek beat consensus on both EPS and revenue, with quarterly revenue well above expectations. Earnings beats and stronger-than-expected sales are positive catalysts for the stock.
🍭 Bonus (B): 0/10 — Misc Chemical Products

🏢 What they do: TechnipFMC plc (NYSE: FTI) is a technology provider to the traditional and new energy industries, delivering fully integrated projects, products, and services through its two main segments: Subsea and Surface Technologies.
- 🎯 At/above 3yr high $78.61 (current $78.61) · ⏳ SMA200 $61.33 (current price $78.61 is above) · 💰 Market Cap $30.9B
- FTI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 41% (>20%); ROE 36% (>15%); Low LT D/E 0.12 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (7.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ TechnipFMC Announces Second-Quarter 2026 Results — Business Wire.
🤖 TechnipFMC reported Q2 2026 revenue of $2.76 billion and adjusted EPS of $0.91, both above expectations, and raised parts of its full-year outlook. The strong results and higher guidance are constructive for the stock.
✅ TechnipFMC Q2 Earnings & Revenues Beat Estimates, Rise Y/Y — Yahoo Finance.
🤖 This article highlights that FTI beat analyst estimates on both earnings and revenue, with EPS and sales rising year over year. It also points to a higher 2026 free cash flow outlook, which supports a positive stock view.
✅ TechnipFMC (NYSE:FTI) Reports Bullish Q2 CY2026 — Yahoo Finance.
🤖 The report emphasizes a strong quarterly beat on revenue, EPS, and adjusted EBITDA, along with improving margins. Those operational trends are favorable for investor sentiment.
🍭 Bonus (B): 0/10 — Oil & Gas Field Machinery

🏢 What they do: Darling Ingredients Inc. transforms animal by-products and food industry waste into sustainable ingredients across three segments: Feed (for animal nutrition, fertilizers, and renewable fuels), Food (for human health), and Fuel (low-emission energy solutions like renewable diesel).
- 🎯 Current $67.04 is 2% below 3yr high $68.38 · ⏳ SMA200 $50.88 (current price $67.04 is above) · 💰 Market Cap $10.6B
- DAR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 2912% (>20%); Revenue growth 16% (>15%); Low LT D/E 0.35 (<1.0); PEG ratio 0.01 (<1.5).
⏰ Entry (E): 4/20
- 🔔 Strong above EMA21 (8.5%)
- 🔔 Strong above EMA50 (11.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Darling Ingredients (NYSE:DAR) Given New $80.00 Price Target at TD Cowen — MarketBeat.
🤖 TD Cowen raised its price target on DAR to $80 from $70 and kept a buy rating, signaling increased analyst confidence after the company’s strong quarter. A higher target and bullish rating are generally supportive for the stock.
✅ Darling Ingredients Inc. Reports Second Quarter 2026 Results — Business Wire.
🤖 DAR reported $2.41 in GAAP diluted EPS, net sales of $1.7 billion, and combined adjusted EBITDA of $741.7 million, all reflecting a sharp year-over-year improvement. Strong profitability, debt reduction, and business sales support a favorable stock view.
✅ Darling Ingredients (DAR) Q2 Earnings Surpass Estimates — Yahoo Finance.
🤖 The company beat earnings expectations with $2.41 EPS, well above consensus, which is typically positive for the share price. Although revenue missed estimates slightly, the large earnings beat and improved year-over-year performance are the dominant signals.
🍭 Bonus (B): 0/10 — Food & Kindred Products